Improving quality, affordability, and equity of multiple sclerosis care

OBJECTIVE: The prevailing approaches to selecting multiple sclerosis (MS) disease modifying therapies (DMTs) have contributed to exponential increases in societal expenditures and out‐of‐pocket expenses, without compelling evidence of improved outcomes. Guidance is lacking regarding when and in whom...

Descripción completa

Detalles Bibliográficos
Autores principales: Langer‐Gould, Annette, Klocke, Shilpa, Beaber, Brandon, Brara, Sonu M., Debacker, Julie, Ayeni, Oluwasheyi, Nielsen, Allen S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Point of View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045931/
https://www.ncbi.nlm.nih.gov/pubmed/33751857
http://dx.doi.org/10.1002/acn3.51326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045931/
https://www.ncbi.nlm.nih.gov/pubmed/33751857
http://dx.doi.org/10.1002/acn3.51326

Ejemplares similares